Findings

What do systematic reviews say?

3,241 questions · 3,336 findings · 1,340 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,581 · 47.4%GRADE not reported 352 · 10.6%Very low 512 · 15.3%Low 509 · 15.3%Moderate 316 · 9.5%High 66 · 2%

Prebiotics and anti‐inflammatory therapy vs anti‐inflammatory therapy

Quality of life · Patients with active mild to moderate ulcerative colitis

The review found no eligible studies for this question.

1 finding from 1 review

Prebiotics for induction and maintenance of remission in ulcerative colitis 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Inulin and oligofructose 15 g vs inulin and oligofructose 7.5 g daily

Quality of life · Patients with active mild to moderate ulcerative colitis

The review found no eligible studies for this question.

1 finding from 1 review

Prebiotics for induction and maintenance of remission in ulcerative colitis 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Test‐based attendance vs routine isolation after contact with a SARS‐CoV‐2 positive person

Quality of life · school staff

The review found no eligible studies for this question.

1 finding from 1 review

Workplace interventions to reduce the risk of SARS‐CoV‐2 infection outside of healthcare settings 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antioxidants (lycopene, curcumin, Oxitard) vs Placebo or no active treatment

Quality of life · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for managing oral submucous fibrosis 2024 · Cochrane All outcomes
The trials did not measure quality of life.
0 studies
No studies found

Adjunctive antimicrobial photodynamic therapy (aPDT) applied after subgingival instrumentation (SI) vs Subgingival instrumentation (SI) alone (hand or power-driven, or both), or SI plus placebo/sham aPDT

Quality of life · Adults (> 18 years) with recurrent periodontitis, receiving supportive (maintenance) periodontal care

The review found no eligible studies for this question.

1 finding from 1 review

Adjunctive antimicrobial photodynamic therapy for treating periodontal and peri‐implant diseases 2024 · Cochrane All outcomes
No studies reported data for this outcome.
Studies not reported
No studies found

Intervention not reported

Quality of life

1 finding from 1 review

Strategies to integrate oral health into primary care: a systematic review. 2023 All outcomes
1 study reported an unfavourable outcome
1 study
GRADE not reported

Lutein with or without zeaxanthin vs placebo

Quality of life · people with AMD

1 finding from 1 review

Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 308 participants
Moderate

Vitamin E vs placebo

Quality of life · people with AMD

The review found no eligible studies for this question.

1 finding from 1 review

Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Zinc vs placebo

Quality of life · people with AMD

The review found no eligible studies for this question.

1 finding from 1 review

Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antioxidant multivitamin and mineral supplement vs placebo or no treatment

Quality of life · people with AMD

1 finding from 1 review

Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 110 participants
Low

Medically assisted hydration vs usual care

Quality of life · adults aged 18 years and older receiving palliative care

The review found no eligible studies for this question.

1 finding from 1 review

Medically assisted hydration for adults receiving palliative care 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings 2: PLD alone vs other conventional chemotherapy

Quality of life · recurrent platinum‐resistant EOC

The review found no eligible studies for this question.

1 finding from 1 review

Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings 1: PLD with chemotherapy vs PLD alone

Quality of life · recurrent platinum‐resistant EOC

The review found no eligible studies for this question.

1 finding from 1 review

Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cerebrolysin or Cerebrolysin‐like agents vs placebo

Quality of life · people with acute ischemic stroke

The review found no eligible studies for this question.

1 finding from 1 review

Cerebrolysin for acute ischaemic stroke 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings ‐ nebulisers for delivering tobramycin: conventional systems vs VMT and AAD

Quality of life · children aged 6 ‐ 18 with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Nebuliser systems for drug delivery in cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Quality of life · children and adults with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Nebuliser systems for drug delivery in cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings ‐ nebulisers for delivering tobramycin: conventional systems vs AAD

Quality of life · adults and children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Nebuliser systems for drug delivery in cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings ‐ nebulisers for delivering tobramycin: VMT and AAD tidal breathing mode (TBM) vs VMT and AAD target inhalation mode (TIM)

Quality of life · adults and children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Nebuliser systems for drug delivery in cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings ‐ nebulisers for delivering colistin: conventional systems vs AAD

Quality of life · adults and children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Nebuliser systems for drug delivery in cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings ‐ nebulisers for delivering colistin and dornase alfa: VMT and AAD tidal breathing mode (TBM) vs VMT and AAD target inhalation mode (TIM)

Quality of life · children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Nebuliser systems for drug delivery in cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found